Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;52(4):104739.
doi: 10.1016/j.respol.2023.104739. Epub 2023 Feb 8.

Vaccine technology transfer in a global health crisis: Actors, capabilities, and institutions

Elize Massard da Fonseca  1 , Kenneth C Shadlen  2 , Helena de Moraes Achcar  1
Affiliations

Vaccine technology transfer in a global health crisis: Actors, capabilities, and institutions

Elize Massard da Fonseca et al. Res Policy. 2023 May.

Abstract

The COVID-19 pandemic, which featured international pharmaceutical firms seeking to build global manufacturing networks to scale-up the supply of vaccines, has generated heightened interest in understanding the role of firm-to-firm technology transfer. While considerable attention has been given to tracking the extent of international vaccine technology transfer, we know little about how partnerships were established and work in practice. Understanding the challenges that such projects face, and how such challenges may be overcome, is crucially important. This paper provides an account of the partnership between the British-Swedish multinational pharmaceutical company AstraZeneca, the vaccine developer that has engaged in the most technology transfer and built the widest global manufacturing network, and Bio-Manguinhos, a public laboratory linked to Brazil's Ministry of Health. The case study demonstrates the importance of capabilities and regulatory flexibility. Moreover, the analysis highlights the role of political factors that affect the process of technology transfer, and innovation more broadly. Because of the risks involved and the need to quickly mobilize existing capabilities and build new ones, as well as the imperatives of coordinating among manufacturing and regulatory processes and allocating resources to make such arrangements feasible, technology transfer projects need to be enabled politically. Looking forward, the case study has implications for initiatives to expand technology transfer for broadened production of vaccines in the Global South.

Keywords: COVID-19; Global South; Pharmaceutical industries; Technology transfer; Vaccine production.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Agarwal S., Gupta A., Dayal R. Technology transfer perspectives in globalising India (drugs and pharmaceuticals and biotechnology) J. Technol. Transf. 2007;32:397–423.
    1. Agência Câmara de Notícias . Agência Câmara de Notícias; 2020. Deputados querem medida provisória para garantir recursos para vacina contra Covid-19. Aug 27.
    1. Agencia Fiocruz . Agencia Fiocruz; 2022. Fiocruz recebe registro da vacina Covid-19 100% nacional. Jan 7.
    1. Barbosa A., Fialho B., Teles E., Pinto R. In: A primeira vacina 100% brasileira contra a Covid-19: a conquista de Bio-Manguinhos. Medeiros M., Soares P., Fialho B., Lacerda D., editors. BioManguinhos / Fiocruz; Rio de Janeiro: 2022. Transferência de Tecnologia.
    1. Barnes-Weise J., Santos Rutschman A., Adler R. Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem. J. Epidemiol. Community Health. 2022;76:317–318. - PMC - PubMed

LinkOut - more resources